Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-06-21
DOI
10.3389/fphar.2019.00693
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Carnosine Prevents Aβ-Induced Oxidative Stress and Inflammation in Microglial Cells: A Key Role of TGF-β1
- (2019) Giuseppe Caruso et al. Cells
- Neuroprotective effects of INT-777 against Aβ 1–42 -induced cognitive impairment, neuroinflammation, apoptosis, and synaptic dysfunction in mice
- (2018) Xian Wu et al. BRAIN BEHAVIOR AND IMMUNITY
- Can Animal Models Inform on the Relationship between Depression and Alzheimer Disease?
- (2018) Jennifer N. K. Nyarko et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Modulation of Inflammation as a Way of Delaying Alzheimer's Disease Progression: The Diet's Role
- (2018) R. Businaro et al. Current Alzheimer Research
- Sub-efficacious doses of phosphodiesterase 4 and 5 inhibitors improve memory in a mouse model of Alzheimer's disease
- (2018) Walter Gulisano et al. NEUROPHARMACOLOGY
- Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target
- (2018) Filippo Caraci et al. PHARMACOLOGICAL RESEARCH
- Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment
- (2018) Dunja Knezevic et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Vortioxetine Treatment Reverses Subchronic PCP Treatment-Induced Cognitive Impairments: A Potential Role for Serotonin Receptor-Mediated Regulation of GABA Neurotransmission
- (2018) Alan L. Pehrson et al. Frontiers in Pharmacology
- Late-Life Depression versus Amnestic Mild Cognitive Impairment: Alzheimer’s Disease Incidence in 4 Years of Follow-Up
- (2018) Michele Lauriola et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Synaptotoxic Amyloid-β Oligomers: A Molecular Basis for the Cause, Diagnosis, and Treatment of Alzheimer's Disease?
- (2018) William L. Klein JOURNAL OF ALZHEIMERS DISEASE
- Pivotal role of carnosine in the modulation of brain cells activity: Multimodal mechanism of action and therapeutic potential in neurodegenerative disorders
- (2018) Giuseppe Caruso et al. PROGRESS IN NEUROBIOLOGY
- Synaptic dysfunction in Alzheimer's disease: From the role of amyloid β-peptide to the α-secretase ADAM10
- (2017) Stefano Musardo et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Distinct Antidepressant-Like and Cognitive Effects of Antidepressants with Different Mechanisms of Action in Middle-Aged Female Mice
- (2017) Yan Li et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Astrocyte Transforming Growth Factor Beta 1 Protects Synapses against Aβ Oligomers in Alzheimer's Disease Model
- (2017) Luan Pereira Diniz et al. JOURNAL OF NEUROSCIENCE
- Fluoxetine administration during adolescence attenuates cognitive and synaptic deficits in adult 3×TgAD mice
- (2017) Dong-Sheng Sun et al. NEUROPHARMACOLOGY
- Antidepressant drugs for beta amyloid-induced depression: A new standpoint?
- (2017) Stefania Schiavone et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Fluoxetine attenuates the impairment of spatial learning ability and prevents neuron loss in middle-aged APPswe/PSEN1dE9 double transgenic Alzheimer’s disease mice
- (2017) Jing Ma et al. Oncotarget
- Beta-amyloid deposition in patients with major depressive disorder with differing levels of treatment resistance: a pilot study
- (2017) Peng Li et al. EJNMMI Research
- Early effects of Aβ 1-42 oligomers injection in mice: Involvement of PI3K/Akt/GSK3 and MAPK/ERK1/2 pathways
- (2016) Fabiana Morroni et al. BEHAVIOURAL BRAIN RESEARCH
- A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults
- (2016) Michael E. Thase et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- High amyloid-β deposition related to depressive symptoms in older individuals with normal cognition: a pilot study
- (2016) Fumihiko Yasuno et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials
- (2016) RS McIntyre et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Cross Talk Between Brain Innate Immunity and Serotonin Signaling Underlies Depressive-Like Behavior Induced by Alzheimer's Amyloid- Oligomers in Mice
- (2016) J. H. Ledo et al. JOURNAL OF NEUROSCIENCE
- Long-term Ameliorative Effects of the Antidepressant Fluoxetine Exposure on Cognitive Deficits in 3 × TgAD Mice
- (2016) Li Jin et al. MOLECULAR NEUROBIOLOGY
- Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria
- (2016) Roberto Federico Villa et al. NEUROSCIENCE
- The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß 1-42 oligomers in mice
- (2016) Gian Marco Leggio et al. PHARMACOLOGICAL RESEARCH
- Role of neuro-immunological factors in the pathophysiology of mood disorders
- (2016) Anindya Bhattacharya et al. PSYCHOPHARMACOLOGY
- Fluoxetine Prevents Aβ1-42-Induced Toxicity via a Paracrine Signaling Mediated by Transforming-Growth-Factor-β1
- (2016) Filippo Caraci et al. Frontiers in Pharmacology
- Treatment of cognitive dysfunction in major depressive disorder—a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine
- (2015) Alan L. Pehrson et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- 5-HT2A receptors are involved in cognitive but not antidepressant effects of fluoxetine
- (2015) Anna Castañé et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Acute amnestic encephalopathy in amyloid-β oligomer–injected mice is due to their widespread diffusion in vivo
- (2015) Stéphane Epelbaum et al. NEUROBIOLOGY OF AGING
- Involvement of 5-HT7 receptors in vortioxetine's modulation of circadian rhythms and episodic memory in rodents
- (2015) Ligia Westrich et al. NEUROPHARMACOLOGY
- Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
- (2015) Connie Sanchez et al. PHARMACOLOGY & THERAPEUTICS
- Reversal of age-associated cognitive deficits is accompanied by increased plasticity-related gene expression after chronic antidepressant administration in middle-aged mice
- (2015) Yan Li et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- A key role for TGF-β1 in hippocampal synaptic plasticity and memory
- (2015) Filippo Caraci et al. Scientific Reports
- In Vivo Application of beta Amyloid Oligomers: A Simple Tool to Evaluate Mechanisms of Action and New Therapeutic Approaches
- (2015) Claudia Balducci et al. CURRENT PHARMACEUTICAL DESIGN
- Fluoxetine Improves Behavioral Performance by Suppressing the Production of Soluble β-Amyloid in APP/PS1 Mice
- (2014) Junhui Wang et al. Current Alzheimer Research
- Depression and the risk for dementia
- (2012) Lars Vedel Kessing CURRENT OPINION IN PSYCHIATRY
- Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice
- (2012) J H Ledo et al. MOLECULAR PSYCHIATRY
- Early and adult hippocampal TGF-β1 overexpression have opposite effects on behavior
- (2011) Amaicha Mara Depino et al. BRAIN BEHAVIOR AND IMMUNITY
- The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression
- (2011) Filippo Caraci et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression — No influence of celecoxib treatment
- (2011) R. Musil et al. JOURNAL OF AFFECTIVE DISORDERS
- Intracellular Aβ-oligomers and early inflammation in a model of Alzheimer's disease
- (2011) Maria Teresa Ferretti et al. NEUROBIOLOGY OF AGING
- Soluble βamyloid1-42: a critical player in producing behavioural and biochemical changes evoking depressive-related state?
- (2010) M Colaianna et al. BRITISH JOURNAL OF PHARMACOLOGY
- TGF-β1 Pathway as a New Target for Neuroprotection in Alzheimer's Disease
- (2009) Filippo Caraci et al. CNS Neuroscience & Therapeutics
- Antidepressants and dementia
- (2009) Lars Vedel Kessing et al. JOURNAL OF AFFECTIVE DISORDERS
- -Amyloid Monomers Are Neuroprotective
- (2009) M. L. Giuffrida et al. JOURNAL OF NEUROSCIENCE
- Object recognition memory and the rodent hippocampus
- (2009) N. J. Broadbent et al. LEARNING & MEMORY
- TGF-β1 protects against Aβ-neurotoxicity via the phosphatidylinositol-3-kinase pathway
- (2008) Filippo Caraci et al. NEUROBIOLOGY OF DISEASE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started